stocks logo

NTLA Valuation

Intellia Therapeutics Inc
$
13.555
+0.775(6.064%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings

NTLA Relative Valuation

NTLA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NTLA is overvalued; if below, it's undervalued.

Historical Valuation

Intellia Therapeutics Inc (NTLA) is now in the Fair zone, suggesting that its current forward PS ratio of 28.51 is considered Fairly compared with the five-year average of -11.57. The fair price of Intellia Therapeutics Inc (NTLA) is between 6.19 to 61.35 according to relative valuation methord.
Relative Value
Fair Zone
6.19-61.35
Current Price:12.78
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.69
P/B
Median3y
2.60
Median5y
4.98
-25.84
FCF Yield
Median3y
-18.34
Median5y
-12.16

Competitors Valuation Multiple

The average P/S ratio for NTLA's competitors is 12.49, providing a benchmark for relative valuation. Intellia Therapeutics Inc Corp (NTLA) exhibits a P/S ratio of 30.10, which is 140.90% above the industry average. Given its robust revenue growth of -42.54%, this premium appears unsustainable.

FAQ

arrow icon

Is Intellia Therapeutics Inc (NTLA) currently overvalued or undervalued?

Intellia Therapeutics Inc (NTLA) is now in the Fair zone, suggesting that its current forward PS ratio of 28.51 is considered Fairly compared with the five-year average of -11.57. The fair price of Intellia Therapeutics Inc (NTLA) is between 6.19 to 61.35 according to relative valuation methord.
arrow icon

What is Intellia Therapeutics Inc (NTLA) fair value?

arrow icon

How does NTLA's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for Intellia Therapeutics Inc (NTLA) as of Jul 25 2025?

arrow icon

What is the current FCF Yield for Intellia Therapeutics Inc (NTLA) as of Jul 25 2025?

arrow icon

What is the current Forward P/E ratio for Intellia Therapeutics Inc (NTLA) as of Jul 25 2025?

arrow icon

What is the current Forward P/S ratio for Intellia Therapeutics Inc (NTLA) as of Jul 25 2025?